medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2005, Number 2

<< Back Next >>

Rev Invest Clin 2005; 57 (2)

Hematopoietic stem-cell transplantation using umbilical-cord blood cells

Rocha V, Garnier F, Ionescu I, Gluckman E

Language: Spanish
References: 62
Page: 314-323
PDF size: 75.32 Kb.


Text Extraction

Umbilical-cord blood transplantation (UCBT) has extended the availability of allogeneic hematopoietic stem-cell transplantation (HSCT) to patients who would otherwise not be eligible for this curative approach. Since the first successful UCBT from an HLA-identical sibling in a child with severe Fanconi’s anemia reported by Gluckman et al. in 1989,1 the number of UCB transplants from siblings and unrelated donors has increased dramatically, and between 3,000 to 6,000 patients have undergone UCBT from unrelated donors thus far.


REFERENCES

  1. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.

  2. Wernet P. The Netcord inventory and use. July 12, 2002. Accessed and available January 11, 2005 at: http://office.de.netcord.org/inventory.gif

  3. Barker JN, Krepski TP, DeFor T, et al. Searching for unrelated donor hematopoietic stem-cell grafts: availability and speed of umbilical-cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-60.

  4. Dalle JH, Duval M, Moghrabi A, et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33: 605-11.

  5. Davey S, Armitage S, Rocha V, et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 2004; 125: 358-65.

  6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-81.

  7. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342: 1846-54.

  8. Locatelli F, Rocha V, Reed W, et al. Related umbilical-cord blood transplant in patients with Thalassemia and Sickle Cell Disease. Blood 2003; 101: 2137-43.

  9. Michel G, Rocha V, Chevret S, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003; 101: 351-7.

  10. Reed W, Smith R, Dekovic F, et al. Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood 2003; 102: 4290-7.

  11. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.

  12. Ohnuma K, Isoyama K, Nishihira H. Cord blood transplantation from HLA-mismatched unrelated donors. Leuk Lymphoma 2002; 43: 1029-43.

  13. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem-cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-66.

  14. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical-cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-18.

  15. Styczynski J, Cheung YK, Garvin J, et al. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2004; 34: 129-36.

  16. Yu LC, Wall DA, Sandler E, et al. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium. Pediatr Hematol Oncol 2001; 18: 235-45.

  17. Staba SL, Escolar ML, Poe M, et al. Cord blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 2004; 350: 1960-9.

  18. Benito AI, Diaz MA, Gonzalez-Vincent M, et al. Hematopoietic stem-cell transplantation using umbilical-cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675-90.

  19. Gluckman E, Rocha V, Arcese W, et al. Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.

  20. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical-cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717-22.

  21. Iori AP, Cerretti R, De Felice L, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing unrelated cord blood transplantation. Bone Marrow Transplant 2004; 33: 1097-105.

  22. Stevens CE, Gladstone J, Taylor PE, et al. Placental/umbilical-cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002; 100: 2662-4.

  23. Rocha V, Cornish J, Sievers E, et al. Comparison of outcomes of unrelated bone marrow and umbilical-cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-71.

  24. Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical-cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957-61.

  25. Sanz G, Rocha V. Umbilical-cord blood transplantation: current status and future directions. Curr Opin Organ Transpl 2003; 8: 109-17.

  26. Moscardo F, Sanz GF, Sanz MA. Unrelated-donor cord blood transplantation for adult hematological malignancies. Leuk Lymphoma 2004; 45: 11-8.

  27. Koh LP, Chao NJ. Umbilical-cord blood transplantation in adults using myeloablative and non-myeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 1-22.

  28. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-22.

  29. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001; 98: 2332-8.

  30. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489-91.

  31. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003; 101: 4711-3.

  32. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical-cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772-80.

  33. Rocha V, Arcese W, Sanz G, et al. Prognostic factors of outcome after unrelated cord blood transplant in adults with hematological malignancies. Blood 2000; 96: 587a (abstract).

  34. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematological malignancies. Blood 2004; 104: 3813-20.

  35. Rocha V, Labopin M, Sanz G, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-85

  36. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-75.

  37. Niehues T, Rocha V, Filipovich A, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. Br J Haematol 2001; 114: 42-8.

  38. Ballen K, Broxmeyer HE, McCullough J, et al. Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001; 7: 635-45.

  39. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-76.

  40. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical-cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aastrom Replicell System. Blood 2003; 101: 5061-7.

  41. McNiece I. Ex vivo expansion of hematopoietic cells. Exp Hematol 2004; 32: 409-10.

  42. Peled T, Landau E, Mandel J, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32: 547-55.

  43. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 1870-1.

  44. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, et al. Transplantation of 2 partially HLA-matched umbilical-cord blood units to enhance engraftment in adults with hematological malignancy. Blood 2005; 105: 1343-7.

  45. Hamsa NS, Fanning L, Tary-Lehmann M, et al. High rate of graft failure after infusion of multiple (3-5) umbilical-cord blood (UCB) units in adults with hematological disorders: role of HLA disparity and UCB graft cell cross immune reactivation. Blood 2003; 98(abstract).

  46. Fernandez MN, Regidor C, Cabrera R, et al. Unrelated umbilical-cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535-44.

  47. Kim DW, Chung YJ, Kim TG, et al. Co transplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941-8.

  48. Mazurier F, Doedens M, Gan OI, et al. Rapid myelo erythroid repopulation after intra femoral transplantation of NOD-SCID mice reveals a new class of human stem-cells. Nat Med 2003; 9: 959-63.

  49. Castello S, Podesta M, Menditto VG, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 2004; 32: 782-7.

  50. Hagglund J. et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 1998; 21: 331-51.

  51. Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical-cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-9.

  52. Chao NJ, Koh LP, Long GD, et al. Adult recipients of umbilical-cord blood transplants after non-myeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 569-75.

  53. Del Toro G, Satwani P, Harrison L, et al. A pilot study of reduced intensity conditioning and allogeneic stem-cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613-22.

  54. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem-cell transplantation. Blood 2002; 99: 1458-64.

  55. Montagna D, Locatelli F, Moretta A, et al. T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. Blood 2004; 103: 4322-9.

  56. Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical-cord blood transplantation. Biol Blood Marrow Transplant 2001; 7: 454-66.

  57. Hamsa NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical-cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004; 124: 488-98.

  58. Barker JN, Martin PL, Coad JE, et al. Low incidence of Epstein-Barr virus-associated post transplantation lymphoproliferative disorders in 272 unrelated-donor umbilical-cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395-9.

  59. Sashihara J, Tonaka-Taya K, Tanaka S, et al. High incidence of human herpes virus 6 infection with a high viral load in cord blood stem-cell transplant recipients. Blood 2002; 100: 2005-11.

  60. Tomonari A, Iseki T, Takahashi S, et al. Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation. Ann Hematol. [in press]

  61. Tomonari A, Takahashi S, Iseki T, et al. Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan. Bone Marrow Transplant 2004; 33: 317-20.

  62. Tomonari A, Iseki T, Takahashi S, et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 2003; 122: 802-5.




2020     |     www.medigraphic.com